- Country: USA
- Summary: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid And/Or Stimulants Use Disorders (Oud/Stud) (R43/R44 - Clinical Trial Optional)
- UST Ref No: 64830206
- Deadline: 14 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-DA-23-021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
CFDA Number : 93.279 -- Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Feb 14, 2025
Posted Date : Mar 28, 2022
Description: This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research projects, directed towards commercialization, for the development of novel, evidence-based, FDA-regulated medical products addressing the needs of patients suffering from opioid use disorders (OUD) and stimulant use disorders (StUD). Applications received under this FOA may fall within two scientific areas, namely: (1) pharmacotherapeutics (small molecules and biologics; and (2) medical therapeutic and diagnostic devices, including software as a medical device. This FOA strives to contribute to the effort against national opioid and psychostimulant emergency and offer new medical products for individuals, families, and communities affected by this devastating crisis. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDeveloping Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid And/Or Stimulants Use Disorders (Oud/Stud) (R43/R44 - Clinical Trial Optional) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid And/Or Stimulants Use Disorders (Oud/Stud) (R43/R44 - Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 64830206 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
